Ento-A alleviates DSS-induced experimental colitis in mice by remolding intestinal microbiota to regulate SCFAs metabolism and the Th17 signaling pathway-Reference-Cited by-同舟云学术

Ento-A alleviates DSS-induced experimental colitis in mice by remolding intestinal microbiota to regulate SCFAs metabolism and the Th17 signaling pathway

Published:2024-01 Issue: Volume:170 Page:115985
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Zhao Hairong,Wang Qian,Zhao Jie,Wang Dexiao,Liu Heng,Gao Pengfei,Shen Yongmei,Wu Taoqing,Wu Xiumei,Zhao Yu,Zhang Chenggui^ORCID

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference72 articles.

1. Epidemiology and risk factors for IBD;Ananthakrishnan;Nat. Rev. Gastroenterol. Hepatol.,2015

2. Epidemiology and natural history of inflammatory bowel diseases;Cosnes;Gastroenterology,2011

3. Immunopathogenesis of IBD: current state of the art;de Souza;Nat. Rev. Gastroenterol. Hepatol.,2016

4. Mesalazine (5-aminosalicylic acid) induced chronic hepatitis;Deltenre;Gut,1999

5. Mesalazine as a cause of fetal anemia and hydrops fetalis: A case report;Ek;Med. (Baltim. ),2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting TNF-α: The therapeutic potential of certolizumab pegol in the early period of cerebral ischemia reperfusion injury in mice;International Immunopharmacology;2024-08

2. Turtle peptide and its derivative peptide ameliorated DSS-induced ulcerative colitis by inhibiting inflammation and modulating the composition of the gut microbiota;International Immunopharmacology;2024-05

3. Crosstalk between hypoxia-inducible factor-1α and short-chain fatty acids in inflammatory bowel disease: key clues toward unraveling the mystery;Frontiers in Immunology;2024-03-28